Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             75 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute graft versus host disease after orthotopic liver transplantation Rogulj, Inga Mandac
2012
5 1 artikel
2 Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia Chen, Huan
2012
5 1 artikel
3 Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go Lv, Meng
2012
5 1 artikel
4 Alterations in the ribosomal machinery in cancer and hematologic disorders Shenoy, Niraj
2012
5 1 artikel
5 Altered expression of the TCR signaling related genes CD3 and FcεRIγ in patients with aplastic anemia Li, Bo
2012
5 1 artikel
6 Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia Zha, Xianfeng
2012
5 1 artikel
7 Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy Sun, Weijing
2012
5 1 artikel
8 A novel monoclonal antibody of human stem cell factor inhibits umbilical cord blood stem cell ex vivo expansion Fan, Jie
2012
5 1 artikel
9 A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide Wang, Eunice S
2012
5 1 artikel
10 Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study Galimberti, Sara
2012
5 1 artikel
11 Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia Li, Ning
2012
5 1 artikel
12 Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial Zinzani, Pier Luigi
2012
5 1 artikel
13 Can EGFR-TKIs be used in first line treatment for advanced non-small cell lung cancer based on selection according to clinical factors ? -- A literature-based meta-analysis Xu, Chongrui
2012
5 1 artikel
14 Challenges to improved therapeutics for metastatic castrate resistant prostate cancer: from recent successes and failures Huang, Xuan
2012
5 1 artikel
15 Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients Wang, Yan-Fang
2012
5 1 artikel
16 Clinical applications of mesenchymal stem cells Wang, Shihua
2012
5 1 artikel
17 Comparative mitochondrial proteomics: perspective in human diseases Jiang, Yujie
2012
5 1 artikel
18 Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma Chauchet, Adrien
2012
5 1 artikel
19 Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia Zou, Limin
2012
5 1 artikel
20 Current management and novel agents for malignant melanoma Lee, Byung
2012
5 1 artikel
21 Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide Sugimoto, Yuka
2012
5 1 artikel
22 Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness Predina, Jarrod D
2012
5 1 artikel
23 Deprivation of arginine by recombinant human arginase in prostate cancer cells Hsueh, Eddy C
2012
5 1 artikel
24 Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis Tognon, Raquel
2012
5 1 artikel
25 Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols Greaves, Wesley
2012
5 1 artikel
26 Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma Hemminki, Kari
2012
5 1 artikel
27 Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia Zou, Yong
2012
5 1 artikel
28 Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies Xuan, Li
2012
5 1 artikel
29 EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis Yang, Zu-Yao
2012
5 1 artikel
30 Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF Roy, Sanchita
2012
5 1 artikel
31 Generation and characterization of a highly effective protein substrate for analysis of FLT3 activity Chen, Yun
2012
5 1 artikel
32 Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large b-cell lymphoma: a review of the literature Tirado, Carlos A
2012
5 1 artikel
33 HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas Sosin, Angela M
2012
5 1 artikel
34 Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early Hepatocellular carcinoma in patients with cirrhosis Guo, Yantong
2012
5 1 artikel
35 Homozygous A polymorphism of the complement C1qA276 correlates with prolonged overall survival in patients with diffuse large B cell lymphoma treated with R-CHOP Jin, Xuan
2012
5 1 artikel
36 Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression Chang, David Z
2012
5 1 artikel
37 MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling Virtue, Anthony
2012
5 1 artikel
38 MicroRNAs in B cell development and malignancy Fernando, Thilini R
2012
5 1 artikel
39 MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status Faraoni, Isabella
2012
5 1 artikel
40 Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients Chotirat, Sadudee
2012
5 1 artikel
41 Molecular functions of metallothionein and its role in hematological malignancies Takahashi, Shinichiro
2012
5 1 artikel
42 Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy Rachagani, Satyanarayana
2012
5 1 artikel
43 Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases Gelsi-Boyer, Véronique
2012
5 1 artikel
44 Novel CD20 monoclonal antibodies for lymphoma therapy Cang, Shundong
2012
5 1 artikel
45 Novel human polyomaviruses, Merkel cell polyomavirus and human polyomavirus 9, in Japanese chronic lymphocytic leukemia cases Imajoh, Masayuki
2012
5 1 artikel
46 Novel targeted agents for gastric cancer Liu, Lian
2012
5 1 artikel
47 Novel therapeutic agents for cutaneous T-Cell lymphoma Jain, Salvia
2012
5 1 artikel
48 Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells Hu, Chaoquan
2012
5 1 artikel
49 Outcome of therapy-related myeloid neoplasms treated with azacitidine Fianchi, Luana
2012
5 1 artikel
50 Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis Li, Jie
2012
5 1 artikel
51 Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma Ponti, Giovanni
2012
5 1 artikel
52 Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation Takahashi, Naoto
2012
5 1 artikel
53 Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS) Raza, Azra
2012
5 1 artikel
54 Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome Galili, Naomi
2012
5 1 artikel
55 Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) Kim, Yu Ri
2012
5 1 artikel
56 Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy Guimarães, Cristina
2012
5 1 artikel
57 Recent advances and novel agents for gastrointestinal stromal tumor (GIST) Lamba, Gurpreet
2012
5 1 artikel
58 Recent updates on the role of microRNAs in prostate cancer Hassan, Oudai
2012
5 1 artikel
59 Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies McBride, Ali
2012
5 1 artikel
60 Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw Vincenzi, Bruno
2012
5 1 artikel
61 SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia Albano, Francesco
2012
5 1 artikel
62 Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient Iriyama, Noriyoshi
2012
5 1 artikel
63 Splenomegaly in myelofibrosis—new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors Randhawa, Jasleen
2012
5 1 artikel
64 Successful mobilization using a combination of plerixafor and G-CSF in pediatric patients who failed previous chemomobilization with G-CSF alone and possible complications of the treatment Hong, Kyung Taek
2012
5 1 artikel
65 SU11652 Inhibits tyrosine kinase activity of FLT3 and growth of MV-4-11 cells Guo, Yao
2012
5 1 artikel
66 Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization Wang, Wen-Quan
2012
5 1 artikel
67 Targeted drug delivery for cancer therapy: the other side of antibodies Firer, Michael A
2012
5 1 artikel
68 The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer Labbaye, Catherine
2012
5 1 artikel
69 The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cells Halsey, Christina
2012
5 1 artikel
70 Therapeutic advancement of chronic lymphocytic leukemia Lu, Kang
2012
5 1 artikel
71 The significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis Zhang, Li-Juan
2012
5 1 artikel
72 The significance of low PU.1 expression in patients with acute promyelocytic leukemia Zhu, Xuehua
2012
5 1 artikel
73 The unfolded von Willebrand factor response in bloodstream: the self-association perspective Yuan, Hailong
2012
5 1 artikel
74 Tissue doppler echocardiography detects preclinical markers of cardiac lesion in MDS patients de Castro, Cláudio César Monteiro
2012
5 1 artikel
75 Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD Chim, Chor Sang
2012
5 1 artikel
                             75 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland